According to the drug approval document delivery information released by the NMPA, sildenafil citrate orally disintegrating tablets manufactured by Nanjing Kangchuanji Pharmaceutical Technology Co., Ltd. have been approved for marketing as a Class 4 generic drug under the new chemical drug registration classification, and are deemed to have passed the consistency evaluation.
2026-06-29
A Strong Start to the New Year – Kangchuanji Achieves Multiple Approvals
The new year begins with a wave of good news. Nanjing Kangchuanji Pharmaceutical Technology Co., Ltd. has made an excellent start, backed by professional expertise. According to NMPA drug approval information, the following products have been approved for marketing or have passed consistency evaluation: Famotidine Injection (2ml:20mg), Saxagliptin and Metformin Hydrochloride Extended-Release Tablets (2.5/1000mg and 5/1000mg), Isosorbide Dinitrate Tablets (5mg), Vitamin B6 Injection (100mg/ml), Cefdinir Granules (50mg/0.5g), and Ambroxol and Clenbuterol Oral Solution (1ml: ambroxol hydrochloride 1.5mg and clenbuterol hydrochloride 1μg). Among these, Isosorbide Dinitrate Tablets are the first in China to pass consistency evaluation. As a partner, Kangchuanji provided solid pharmaceutical R&D services, successfully supporting these drugs through the review and approval process.
2026-03-23
Regulatory Approval for Icosapent Ethyl Soft Capsules Achieved with Kangchuanji's Support
According to the drug approval information released by NMPA, our partner has obtained the "Drug Registration Certificate" from the National Medical Products Administration for its Icosapent Ethyl Soft Capsules (0.5 g and 1.0 g), granting marketing authorization. Kangchuanji provided R&D support for this product.
2025-06-09
Quality is the lifeline of an enterprise – its core and soul.
Quality is the lifeline of an enterprise – its core and soul. To further standardize our R&D processes, effectively manage risks, and establish standardized operations and management practices, Nanjing Kangchuanji Pharmaceutical Technology Co., Ltd. passed the ISO 9001 Quality Management System (CNAS) certification in January 2025.
2025-01-26
On July 18-19, the 88th Pharmaceutical QianTuHui Conference & National New Drug R&D and Investment M&A Summit was held at Nanjing Fengda International Hotel. Kangchuanji was invited to attend and set up a booth (Booth No. B02).
2024-07-21